This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Genefrontier Corporation, Keio University. Active years: 2017-2020.
Company Filing History:
2 out of 12 
2 out of 360 
Years Active: 2017-2020
Title: Rena Matsumoto: Innovator in Cancer Treatment
Introduction
Rena Matsumoto is a notable inventor based in Kashiwa, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.
Latest Patents
Matsumoto holds 2 patents related to his work on anti-ADAM28 antibodies for treating cancer. His inventions provide antibodies that specifically bind to human ADAM28, inhibit its enzyme activity, and suppress the metastasis of cancer cells expressing this protein. These antibodies can be developed as human antibodies, showcasing their potential for therapeutic applications.
Career Highlights
Throughout his career, Rena Matsumoto has worked with prominent organizations such as Genefrontier Corporation and Keio University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Matsumoto has collaborated with notable colleagues, including Akira Miyakoshi and Shizue Katoh, who have supported his research endeavors.
Conclusion
Rena Matsumoto's innovative work in developing anti-ADAM28 antibodies represents a significant advancement in cancer treatment. His contributions continue to impact the field and offer hope for future therapies.